Back to Results
First PageMeta Content
Rofecoxib / Sulfones / Medicine / Pharmacology / COX-2 inhibitor / Food and Drug Administration / David Graham / Clinical research / Pharmaceutical sciences / Merck


Retour d’expérience sur le Vioxx® - J. Michael McGinnis
Add to Reading List

Document Date: 2012-05-09 13:59:39

Open Document

File Size: 645,23 KB

Share Result on Facebook

Company

Merck / /

Country

France / /

Event

Product Issues / Product Recall / FDA Phase / /

Facility

MPP Institute of Medicine / IOM The Institute of Medicine One / Institute of Medicine Congressionally-chartered / /

MedicalCondition

Increased heart attack / arthritis / /

Organization

FDA / Institute of Medicine Congressionally-chartered / NDA Agency / Institute of Medicine One / FDA office of Drug Safety / National Academy of Sciences / MPP Institute of Medicine / National Academy of Engineering / /

Person

J. Michael McGinnis / /

Position

Director / /

Product

Vioxx / Vioxx® Timeline / Vioxx® Resources / /

SocialTag